Literature DB >> 2691889

The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage.

E Medina-Acosta1, R E Karess, H Schwartz, D G Russell.   

Abstract

The expression, processing and localization of the promastigote surface glycoprotein, gp63, in the amastigote form of Leishmania mexicana was examined. Metabolically labeled protein was immunoprecipitated from promastigotes and amastigotes. The isolated proteins were subjected to deglycosylation and partial peptide mapping. The cleavage products generated migrated similarly in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, indicating that the proteins were closely related. The majority of gp63 in amastigotes was inaccessible to surface-labeling procedures, and lacked the phosphatidylinositol membrane anchor. Immunolocalization of this subpopulation of gp63 revealed it to be present within the parasite's flagellar pocket. Despite the relative paucity of 'membrane-form' gp63, isolation and analysis of surface proteins from lesion amastigotes indicated that gp63 was the most abundant protein on the amastigote surface.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2691889     DOI: 10.1016/0166-6851(89)90158-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  35 in total

1.  Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro.

Authors:  D Q Chen; B K Kolli; N Yadava; H G Lu; A Gilman-Sachs; D A Peterson; K P Chang
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

Review 2.  Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival.

Authors:  Norikiyo Ueno; Mary E Wilson
Journal:  Trends Parasitol       Date:  2012-06-21

3.  Leishmania mexicana mutants lacking glycosylphosphatidylinositol (GPI):protein transamidase provide insights into the biosynthesis and functions of GPI-anchored proteins.

Authors:  J D Hilley; J L Zawadzki; M J McConville; G H Coombs; J C Mottram
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

4.  Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions.

Authors:  Issa Abu-Dayyeh; Kasra Hassani; Edze R Westra; Jeremy C Mottram; Martin Olivier
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

5.  Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody.

Authors:  C L Barbiéri; S Giorgio; A J Merjan; E N Figueiredo
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.

Authors:  H Charest; G Matlashewski
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

7.  Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera.

Authors:  T Sanyal; D K Ghosh; D Sarkar
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

8.  Secreted acid phosphatase of Leishmania mexicana: a filamentous phosphoglycoprotein polymer.

Authors:  T Ilg; Y D Stierhof; R Etges; M Adrian; D Harbecke; P Overath
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection.

Authors:  Ileana C Cuevas; Juan J Cazzulo; Daniel O Sánchez
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein.

Authors:  Sally Corradin; Adriana Ransijn; Giampietro Corradin; Jacques Bouvier; Maria Belen Delgado; Jimena Fernandez-Carneado; Jeremy C Mottram; Guy Vergères; Jacques Mauël
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.